Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Liver Diseases

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 61 articles: HTML format Text format

Single Articles

September 2019
1. JEE BA, Choi JH, Rhee H, Yoon S, et al
   Dynamics of genomic, epigenomic, and transcriptomic aberrations during stepwise hepatocarcinogenesis.
   Cancer Res. 2019 Sep 10. pii: 0008-5472.CAN-19-0991.
   PubMed     Text format     Abstract available
   
   
   
2. YARCHOAN M, Agarwal P, Villanueva A, Rao S, et al
   Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma.
   Cancer Res. 2019;79:4326-4330.
   PubMed     Text format     Abstract available
   
   
   August 2019
3. XU M, Wang J, Xu Z, Li R, et al
   SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model.
   Cancer Res. 2019 Aug 5. pii: 0008-5472.CAN-18-3750.
   PubMed     Text format     Abstract available
   
   
   July 2019
4. LIM LJ, Wong SYS, Huang F, Lim S, et al
   Roles and Regulation of Long non-coding RNAs in Hepatocellular Carcinoma.
   Cancer Res. 2019 Jul 23. pii: 0008-5472.CAN-19-0255.
   PubMed     Text format     Abstract available
   
   
   
5. ZHANG H, Xing S, Li Z, Ma W, et al
   DIS3L2 promotes progression of hepatocellular carcinoma via hnRNP U-mediated alternative splicing.
   Cancer Res. 2019 Jul 22. pii: 0008-5472.CAN-19-0376.
   PubMed     Text format     Abstract available
   
   
   
6. YOON AR, Hong J, Li Y, Shin HC, et al
   Mesenchymal stem cell-mediated delivery of an oncolytic adenovirus enhances antitumor efficacy in hepatocellular carcinoma.
   Cancer Res. 2019 Jul 9. pii: 0008-5472.CAN-18-3900.
   PubMed     Text format     Abstract available
   
   
   
7. YE YC, Zhao JL, Lu YT, Gao CC, et al
   Notch signaling via Wnt regulates the proliferation of alternative, CCR2-independent tumor-associated macrophages in hepatocellular carcinoma.
   Cancer Res. 2019 Jul 2. pii: 0008-5472.CAN-18-1691.
   PubMed     Text format     Abstract available
   
   
   May 2019
8. LAN T, Yuan K, Yan X, Xu L, et al
   LncRNA SNHG10 facilitates hepatocarcinogenesis and metastasis by modulating its homolog SCARNA13 via a positive feedback loop.
   Cancer Res. 2019 May 17. pii: 0008-5472.CAN-18-4044.
   PubMed     Text format     Abstract available
   
   
   March 2019
9. SUN F, Wang Y, Luo X, Ma Z, et al
   Anti-CD24 antibody-nitric oxide conjugate (ANC) selectively and potently suppresses hepatic carcinoma.
   Cancer Res. 2019 Mar 27. pii: 0008-5472.CAN-18-2839.
   PubMed     Text format     Abstract available
   
   
   
10. TAKAI A, Dang H, Oishi N, Khatib S, et al
    Genome-wide RNAi Screen identifies PMPCB as a therapeutic vulnerability in EpCAM+ hepatocellular carcinoma.
    Cancer Res. 2019 Mar 12. pii: 0008-5472.CAN-18-3015.
    PubMed     Text format     Abstract available
    
    
    
11. FEKIR K, Dubois-Pot-Schneider H, Desert R, Daniel Y, et al
    Retrodifferentiation of human tumor hepatocytes to stem cells leads to metabolic reprogramming and chemoresistance.
    Cancer Res. 2019 Mar 5. pii: 0008-5472.CAN-18-2110.
    PubMed     Text format     Abstract available
    
    
    February 2019
12. KWEE SA, Tiirikainen M, Sato MM, Acoba JD, et al
    Transcriptomics associates molecular features with 18F-fluorocholine PET/CT imaging phenotype and its potential relationship to survival in hepatocellular carcinoma.
    Cancer Res. 2019 Feb 13. pii: 0008-5472.CAN-18-3837.
    PubMed     Text format     Abstract available
    
    
    
13. HAN J, Meng J, Wang X, Yin S, et al
    YY1 complex promotes Quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma.
    Cancer Res. 2019 Feb 13. pii: 0008-5472.CAN-18-2238.
    PubMed     Text format     Abstract available
    
    
    
14. XU F, Li CH, Wong CH, Chen GG, et al
    Genome-wide screening and functional analysis identifies tumor suppressor long non-coding RNAs epigenetically silenced in hepatocellular carcinoma.
    Cancer Res. 2019 Feb 4. pii: 0008-5472.CAN-18-1659.
    PubMed     Text format     Abstract available
    
    
    December 2018
15. CHEN SL, Zhang CZ, Liu LL, Lu SX, et al
    A GYS2/p53 negative feedback loop restricts tumor growth in HBV-related hepatocellular carcinoma.
    Cancer Res. 2018 Dec 24. pii: 0008-5472.CAN-18-2357.
    PubMed     Text format     Abstract available
    
    
    
16. DONG Q, Du Y, Li H, Liu C, et al
    EGFR and c-MET cooperate to enhance resistance to PARP inhibitors in hepatocellular carcinoma.
    Cancer Res. 2018 Dec 20. pii: 0008-5472.CAN-18-1273.
    PubMed     Text format     Abstract available
    
    
    
17. WOHLFEIL SA, Hafele V, Dietsch B, Schledzewski K, et al
    Hepatic endothelial Notch activation protects against liver metastasis by regulating endothelial-tumor cell adhesion independent of angiocrine signaling.
    Cancer Res. 2018 Dec 10. pii: 0008-5472.CAN-18-1752.
    PubMed     Text format     Abstract available
    
    
    
18. GU Y, Wei X, Sun Y, Gao H, et al
    miR-192-5p silencing by genetic aberrations is a key event in hepatocellular carcinomas with cancer stem cell features.
    Cancer Res. 2018 Dec 7. pii: 0008-5472.CAN-18-1675.
    PubMed     Text format     Abstract available
    
    
    November 2018
19. PENG L, Jiang B, Yuan X, Qiu Y, et al
    Super-enhancer-associated long non-coding RNA HCCL5 is activated by ZEB1 and promotes the malignancy of hepatocellular carcinoma.
    Cancer Res. 2018 Nov 27. pii: 0008-5472.CAN-18-0367.
    PubMed     Text format     Abstract available
    
    
    October 2018
20. 
    Correction: Telomerase-dependent Virotherapy Overcomes Resistance of Hepatocellular Carcinomas against Chemotherapy and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand by Elimination of Mcl-1.
    Cancer Res. 2018;78:6026.
    PubMed     Text format    
    
    
    September 2018
21. ROBERTSON CL, Mendoza RG, Jariwala N, Dozmorov M, et al
    Astrocyte elevated gene-1 (AEG-1) regulates macrophage activation in hepatocellular carcinogenesis.
    Cancer Res. 2018 Sep 4. pii: 0008-5472.CAN-18-0659.
    PubMed     Text format     Abstract available
    
    
    August 2018
22. GU L, Zhu Y, Lin X, Li Y, et al
    Amplification of glyceronephosphate O-acyltransferase and recruitment of USP30 stabilize DRP1 to promote hepatocarcinogenesis.
    Cancer Res. 2018 Aug 24. pii: 0008-5472.CAN-18-0340.
    PubMed     Text format     Abstract available
    
    
    July 2018
23. YAO Y, Sun S, Wang J, Fei F, et al
    Canonical Wnt signaling remodels lipid metabolism in zebrafish hepatocytes following Ras oncogenic insult.
    Cancer Res. 2018 Jul 31. pii: 0008-5472.CAN-17-3964.
    PubMed     Text format     Abstract available
    
    
    
24. MAKINO Y, Hikita H, Kodama T, Shigekawa M, et al
    CTGF mediates tumor-stroma interactions between hepatoma cells and hepatic stellate cells to accelerate HCC progression.
    Cancer Res. 2018 Jul 2. pii: 0008-5472.CAN-17-3844.
    PubMed     Text format     Abstract available
    
    
    
25. LI Y, Lin S, Li L, Tang Z, et al
    PDSS2 deficiency induces hepatocarcinogenesis by decreasing mitochondrial respiration and reprogramming glucose metabolism.
    Cancer Res. 2018 Jul 2. pii: 0008-5472.CAN-17-2172.
    PubMed     Text format     Abstract available
    
    
    June 2018
26. QI LN, Xiang BD, Wu FX, Ye JZ, et al
    Circulating tumor cells undergoing EMT provide a metric for diagnosis and prognosis of patients with hepatocellular carcinoma.
    Cancer Res. 2018 Jun 18. pii: 0008-5472.CAN-17-2459.
    PubMed     Text format     Abstract available
    
    
    
27. 
    Retraction: Identification of Brain-Derived Neurotrophic Factor as a Novel Functional Protein in Hepatocellular Carcinoma.
    Cancer Res. 2018;78:3400.
    PubMed     Text format    
    
    
    
28. 
    Retraction: The Potential Role of Hypoxia Inducible Factor 1alpha in Tumor Progression after Hypoxia and Chemotherapy in Hepatocellular Carcinoma.
    Cancer Res. 2018;78:3399.
    PubMed     Text format    
    
    
    
29. HILL MA, Alexander WB, Guo B, Kato Y, et al
    Kras and Tp53 mutations cause cholangiocyte- and hepatocyte-derived cholangiocarcinoma.
    Cancer Res. 2018 Jun 5. pii: 0008-5472.CAN-17-1123.
    PubMed     Text format     Abstract available
    
    
    May 2018
30. MENG J, Chen S, Han J, Qian B, et al
    Twist1 regulates Vimentin through Cul2 circular RNA to promote EMT in hepatocellular carcinoma.
    Cancer Res. 2018 May 29. pii: 0008-5472.CAN-17-3009.
    PubMed     Text format     Abstract available
    
    
    
31. WEN LZ, Ding K, Wang ZR, Ding CH, et al
    SHP-1 acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.
    Cancer Res. 2018 May 18. pii: 0008-5472.CAN-17-3896.
    PubMed     Text format     Abstract available
    
    
    March 2018
32. XU J, Yang Y, Xie R, Liu J, et al
    The NCX1/TRPC6 complex mediates TGFbeta-driven migration and invasion of human hepatocellular carcinoma cells.
    Cancer Res. 2018 Mar 2. pii: 0008-5472.CAN-17-2061.
    PubMed     Text format     Abstract available
    
    
    
33. SAKAI E, Nakayama M, Oshima H, Kouyama Y, et al
    Combined Mutation of Apc, Kras, and Tgfbr2 Effectively Drives Metastasis of Intestinal Cancer.
    Cancer Res. 2018;78:1334-1346.
    PubMed     Text format     Abstract available
    
    
    
34. VERZELLA D, Bennett J, Fischietti M, Thotakura AK, et al
    GADD45beta Loss Ablates Innate Immunosuppression in Cancer.
    Cancer Res. 2018;78:1275-1292.
    PubMed     Text format     Abstract available
    
    
    February 2018
35. CAI Z, Qian ZY, Jiang H, Ma N, et al
    hPCL3s promotes hepatocellular carcinoma metastasis by activating beta-catenin signaling.
    Cancer Res. 2018 Feb 26. pii: 0008-5472.CAN-17-0028.
    PubMed     Text format     Abstract available
    
    
    
36. CHENG BY, Lau EY, Leung HW, Leung CO, et al
    IRAK1 augments cancer stemness and drug resistance via the AP-1/AKR1B10 signaling cascade in hepatocellular carcinoma.
    Cancer Res. 2018 Feb 26. pii: 0008-5472.CAN-17-2445.
    PubMed     Text format     Abstract available
    
    
    
37. LIU C, Liu L, Chen X, Cheng J, et al
    LSD1 Stimulates Cancer-Associated Fibroblasts to Drive Notch3-Dependent Self-Renewal of Liver Cancer Stem-like Cells.
    Cancer Res. 2018;78:938-949.
    PubMed     Text format     Abstract available
    
    
    
38. ZHANG YL, Li Q, Yang XM, Fang F, et al
    SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways.
    Cancer Res. 2018 Feb 13. pii: 0008-5472.CAN-17-2867.
    PubMed     Text format     Abstract available
    
    
    
39. KOHLI S, Bhardwaj A, Kumari R, Das S, et al
    SIRT6 Is a Target of Regulation by UBE3A That Contributes to Liver Tumorigenesis in an ANXA2-Dependent Manner.
    Cancer Res. 2018;78:645-658.
    PubMed     Text format     Abstract available
    
    
    January 2018
40. RHEE H, Kim HY, Choi JH, Woo HG, et al
    Keratin 19 expression in hepatocellular carcinoma is regulated by fibroblast-derived HGF via a MET-ERK1/2-AP1 and SP1 axis.
    Cancer Res. 2018 Jan 23. pii: 0008-5472.CAN-17-0988.
    PubMed     Text format     Abstract available
    
    
    
41. SHEN J, Li P, Shao X, Yang Y, et al
    The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival.
    Cancer Res. 2018;78:359-371.
    PubMed     Text format     Abstract available
    
    
    December 2017
42. JOSHI JJ, Coffey H, Corcoran E, Tsai J, et al
    H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma.
    Cancer Res. 2017;77:6999-7013.
    PubMed     Text format     Abstract available
    
    
    November 2017
43. YAN Q, Jiang L, Liu M, Yu D, et al
    ANGPTL1 Interacts with Integrin alpha1beta1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling.
    Cancer Res. 2017;77:5831-5845.
    PubMed     Text format     Abstract available
    
    
    
44. D'COSTA Z, Jones K, Azad A, van Stiphout R, et al
    Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer.
    Cancer Res. 2017;77:5952-5962.
    PubMed     Text format     Abstract available
    
    
    October 2017
45. ZHANG CZ, Chen SL, Wang CH, He YF, et al
    CBX8 exhibits oncogenic activity via AKT/beta-Catenin activation in hepatocellular carcinoma.
    Cancer Res. 2017 Oct 24. pii: canres.0700.2017.
    PubMed     Text format     Abstract available
    
    
    
46. TSCHIDA BR, Temiz NA, Kuka TP, Lee LA, et al
    Sleeping Beauty insertional mutagenesis in mice identifies drivers of steatosis-associated hepatic tumor.
    Cancer Res. 2017 Oct 9. pii: canres.2281.2017.
    PubMed     Text format     Abstract available
    
    
    September 2017
47. MATSUMOTO T, Takai A, Eso Y, Kinoshita K, et al
    Proliferating EpCAM-positive ductal cells in the inflamed liver give rise to hepatocellular carcinoma.
    Cancer Res. 2017 Sep 26. pii: canres.1800.2017.
    PubMed     Text format     Abstract available
    
    
    
48. TENG Y, Zhao H, Gao L, Zhang W, et al
    FGF19 protects hepatocellular carcinoma cells against endoplasmic reticulum stress via activation of FGFR4-GSK3beta-Nrf2 signaling.
    Cancer Res. 2017 Sep 26. pii: canres.2039.2017.
    PubMed     Text format     Abstract available
    
    
    
49. YAN X, Zhang D, Wu W, Wu S, et al
    Mesenchymal stem cells promote hepatocarcinogenesis via lncRNA-MUF interaction with ANXA2 and miR-34a.
    Cancer Res. 2017 Sep 25. pii: canres.1915.2017.
    PubMed     Text format     Abstract available
    
    
    August 2017
50. MENDEZ-LUCAS A, Li X, Hu J, Che L, et al
    Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1/PKM2 Ratios and Pyruvate Kinase Activities.
    Cancer Res. 2017;77:4355-4364.
    PubMed     Text format     Abstract available
    
    
    
51. YE J, Li TS, Xu G, Zhao YM, et al
    JCAD Promotes Progression of Non-alcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity.
    Cancer Res. 2017 Aug 3. pii: canres.0229.2017.
    PubMed     Text format     Abstract available
    
    
    
52. WANG LT, Chiou SS, Chai CY, Hsi E, et al
    Intestine-Specific Homeobox Gene ISX Integrates IL6 Signaling, Tryptophan Catabolism, and Immune Suppression.
    Cancer Res. 2017;77:4065-4077.
    PubMed     Text format     Abstract available
    
    
    July 2017
53. TILL J, Yoon C, Kim BJ, Roby KC, et al
    Oncogenic KRAS and p53 loss drive gastric tumorigenesis in mice that can be attenuated by E-cadherin expression.
    Cancer Res. 2017 Jul 31. pii: canres.0061.2017.
    PubMed     Text format     Abstract available
    
    
    
54. NG KY, Chan LH, Chai S, Tong M, et al
    TP53INP1 down-regulation activates a p73-dependent DUSP10/ERK signaling pathway to promote metastasis of hepatocellular carcinoma.
    Cancer Res. 2017 Jul 3. pii: canres.3456.2016.
    PubMed     Text format     Abstract available
    
    
    
55. BARBAZAN J, Alonso-Alconada L, Elkhatib N, Geraldo S, et al
    Liver Metastasis Is Facilitated by the Adherence of Circulating Tumor Cells to Vascular Fibronectin Deposits.
    Cancer Res. 2017;77:3431-3441.
    PubMed     Text format     Abstract available
    
    
    June 2017
56. NGO HKC, Kim DH, Cha YN, Na HK, et al
    Nrf2 mutagenic activation drives hepatocarcinogenesis.
    Cancer Res. 2017 Jun 27. pii: canres.3538.2016.
    PubMed     Text format     Abstract available
    
    
    
57. AKIEL M, Guo C, Li X, Rajasekaran D, et al
    IGFBP7 Deletion Promotes Hepatocellular Carcinoma.
    Cancer Res. 2017 Jun 15. pii: canres.2885.2016.
    PubMed     Text format     Abstract available
    
    
    April 2017
58. WANG D, Sun H, Wei J, Cen B, et al
    CXCL1 is critical for pre-metastatic niche formation and metastasis in colorectal cancer.
    Cancer Res. 2017 Apr 28. pii: canres.3199.2016.
    PubMed     Text format     Abstract available
    
    
    
59. JARIWALA N, Rajasekaran D, Mendoza RG, Shen XN, et al
    Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma.
    Cancer Res. 2017 Apr 20. pii: canres.0298.2017.
    PubMed     Text format     Abstract available
    
    
    
60. YUE F, Li W, Zou J, Jiang X, et al
    Spermidine prolongs lifespan and prevents liver fibrosis and hepatocellular carcinoma by activating MAP1S-mediated autophagy.
    Cancer Res. 2017 Apr 6. pii: canres.3462.2016.
    PubMed     Text format     Abstract available
    
    
    March 2017
61. QIAO G, Qin J, Kunda N, Calata J, et al
    LIGHT elevation enhances immune eradication of colon cancer metastases.
    Cancer Res. 2017 Mar 1. pii: canres.1655.2016.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: